1.Simopoulos, AP (1999) Essential fatty acids in health and chronic disease. Am J Clin Nutr 70, Suppl. 3, 560S–569S.
2.Simopoulos, AP (2008) The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Exp Biol Med (Maywood) 233, 674–688.
3.Kris-Etherton, PM, Harris, WS & Appel, LJ (2003) Omega-3 fatty acids and cardiovascular disease: new recommendations from the American Heart Association. Arterioscler Thromb Vasc Biol 23, 151–152.
4.Ailhaud, G, Massiera, F, Weill, P et al. (2006) Temporal changes in dietary fats: role of n-6 polyunsaturated fatty acids in excessive adipose tissue development and relationship to obesity. Prog Lipid Res 45, 203–236.
5.Calder, PC (2003) n-3 Polyunsaturated fatty acids and inflammation: from molecular biology to the clinic. Lipids 38, 343–352.
7.Sampels, S, Strandvik, B & Pickova, J (2009) Processed animal products with emphasis on polyunsaturated fatty acid content. Eur J Lipid Sci Technol 111, 481–488.
8.Mandell, IB, Buchanan-Smith, JG & Campbell, CP (1998) Effects of forage vs grain feeding on carcass characteristics, fatty acid composition, and beef quality in Limousin-cross steers when time on feed is controlled. J Anim Sci 76, 2619–2630.
9.Kitessa, SM, Gulati, SK, Simos, GC et al. (2004) Supplementation of grazing dairy cows with rumen-protected tuna oil enriches milk fat with n-3 fatty acids without affecting milk production or sensory characteristics. Br J Nutr 91, 271–278.
10.Hamilton, MC, Hites, RA, Schwager, SJ et al. (2005) Lipid composition and contaminants in farmed and wild salmon. Environ Sci Technol 39, 8622–8629.
11.Stubbs, CD, KKinosita, Jr, Munkonge, F et al. (1984) The dynamics of lipid motion in sarcoplasmic reticulum membranes determined by steady-state and time-resolved fluorescence measurements on 1,6-diphenyl-1,3,5-hexatriene and related molecules. Biochim Biophys Acta 775, 374–380.
12.Clarke, SD (2004) The multi-dimensional regulation of gene expression by fatty acids: polyunsaturated fats as nutrient sensors. Curr Opin Lipidol 15, 13–18.
13.Institute of Medicine (2005) Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids (Macronutrients). Washington, DC: National Academy Press.
14.Bjerve, KS, Fischer, S & Alme, K (1987) Alpha-linolenic acid deficiency in man: effect of ethyl linolenate on plasma and erythrocyte fatty acid composition and biosynthesis of prostanoids. Am J Clin Nutr 46, 570–576.
15.Plourde, M & Cunnane, SC (2007) Extremely limited synthesis of long chain polyunsaturates in adults: implications for their dietary essentiality and use as supplements. Appl Physiol Nutr Metab 32, 619–634.
16.Brenna, JT, NSalem, Jr, Sinclair, AJ et al. (2009) Alpha-linolenic acid supplementation and conversion to n-3 long-chain polyunsaturated fatty acids in humans. Prostaglandins Leukot Essent Fatty Acids 80, 85–91.
17.Shoda, R, Matsueda, K, Yamato, S et al. (1996) Epidemiologic analysis of Crohn disease in Japan: increased dietary intake of n-6 polyunsaturated fatty acids and animal protein relates to the increased incidence of Crohn's disease in Japan. Am J Clin Nutr 63, 741–745.
18.Dewailly, E, Blanchet, C, Lemieux, S et al. (2001) n-3 Fatty acids and cardiovascular disease risk factors among the Inuit of Nunavik. Am J Clin Nutr 74, 464–473.
19.Griffin, B (2008) How relevant is the ratio of dietary n-6 to n-3 polyunsaturated fatty acids to cardiovascular disease risk? Evidence from the OPTILIP study. Curr Opin Lipidol 19, 57–62.
20.Koletzko, B, Cetin, I & Brenna, JT (2007) Dietary fat intakes for pregnant and lactating women. Br J Nutr 98, 873–877.
21.Koletzko, B, Lien, E, Agostoni, C et al. (2008) The roles of long-chain polyunsaturated fatty acids in pregnancy, lactation and infancy: review of current knowledge and consensus recommendations. J Perinat Med 36, 5–14.
22.Harris, WS, Mozaffarian, D, Lefevre, M et al. (2009) Towards establishing dietary reference intakes for eicosapentaenoic and docosahexaenoic acids. J Nutr 139, issue 4, 804S–819S.
24.Shim, SM, Dorworth, LE, Lasrado, JE et al. (2004) Mercury and fatty acids in canned tuna, salmon, and mackerel. J Food Sci 69, C681–C684.
25.Foran, JA, Good, DH, Carpenter, DO et al. (2005) Quantitative analysis of the benefits and risks of consuming farmed and wild salmon. J Nutr 135, 2639–2643.
26.Guallar, E, Sanz-Gallardo, MI, van't Veer, P et al. (2002) Mercury, fish oils, and the risk of myocardial infarction. N Engl J Med 347, 1747–1754.
28.Food and Nutrition Board, Institute of Medicine (2007) Seafood Choices: Balancing Benefits and Risks. Washington, DC: National Academy Press.
29.Burger, J & Gochfeld, M (2004) Mercury in canned tuna: white versus light and temporal variation. Environ Res 96, 239–249.
30.Yess, NJ (1993) US food and drug administration survey of methyl mercury in canned tuna. J AOAC Int 76, 36–38.
31.Coste, TC, Armand, M, Lebacq, J et al. (2007) An overview of monitoring and supplementation of omega 3 fatty acids in cystic fibrosis. Clin Biochem 40, 511–520.
32.Cawood, AL, Carroll, MP, Wootton, SA et al. (2005) Is there a case for n-3 fatty acid supplementation in cystic fibrosis? Curr Opin Clin Nutr Metab Care 8, 153–159.